EC Number | Application | Comment | Organism |
---|---|---|---|
2.3.1.26 | medicine | the results suggest that the ACAT inhibitor VULM 1457 is a prospective hypolipidemic and anti-atherogenic drug which treats diabetes | Mesocricetus auratus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.26 | 1-(2,6-diisopropyl-phenyl)-3-[4-(4'-nitrophenylthio)phenyl] urea | VULM 1457 | Mesocricetus auratus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.26 | acyl-CoA + cholesterol | Mesocricetus auratus | - |
CoA + cholesterol ester | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.26 | Mesocricetus auratus | - |
Syrian hamster | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.26 | acyl-CoA + cholesterol | - |
Mesocricetus auratus | CoA + cholesterol ester | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.26 | ACAT | two ACAT genes have been identified in mammals, ACAT-1 and ACAT-2 | Mesocricetus auratus |
2.3.1.26 | acyl-coenzyme A:cholesterol O-acyltransferase | - |
Mesocricetus auratus |